agilon health - AGL Stock Forecast, Price & News

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for agilon health in the last twelve months. There are currently 1 hold rating and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" AGL shares.
View AGL analyst ratings or view top-rated stocks.

8 Wall Street research analysts have issued 12 month price targets for agilon health's shares. Their AGL share price forecasts range from $23.00 to $34.00. On average, they predict the company's share price to reach $29.38 in the next year. This suggests a possible upside of 2.4% from the stock's current price.
View analysts price targets for AGL or view top-rated stocks among Wall Street analysts.

agilon health's stock was trading at $16.14 at the beginning of the year. Since then, AGL stock has increased by 77.8% and is now trading at $28.69.
View the best growth stocks for 2023 here.

agilon health saw a increase in short interest in the month of February. As of February 15th, there was short interest totaling 32,720,000 shares, an increase of 8.1% from the January 31st total of 30,260,000 shares. Based on an average daily volume of 1,860,000 shares, the days-to-cover ratio is presently 17.6 days. Approximately 15.7% of the shares of the stock are sold short.
View agilon health's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 4th 2023.
View our AGL earnings forecast.

agilon health, inc. (NYSE:AGL) posted its earnings results on Wednesday, October, 27th. The company reported ($0.09) EPS for the quarter, missing the consensus estimate of ($0.07) by $0.02. The firm had revenue of $458.61 million for the quarter, compared to the consensus estimate of $452.54 million. agilon health had a negative net margin of 3.93% and a negative trailing twelve-month return on equity of 9.33%.

ETFs with the largest weight of agilon health (NYSE:AGL) stock in their portfolio include SPDR S&P Health Care Services ETF (XHS), Harbor Corporate Culture Leaders ETF (HAPY), Renaissance IPO ETF (IPO), iShares U.S. Healthcare Providers ETF (IHF), Fidelity Growth Opportunities ETF (FGRO), Global X Aging Population ETF (AGNG), RiverNorth Patriot ETF (FLDZ) and Fidelity New Millennium ETF (FMIL).

agilon health updated its FY 2023 earnings guidance on Wednesday, March, 1st. The company provided EPS guidance of for the period. The company issued revenue guidance of $4.28 billion-$4.37 billion, compared to the consensus revenue estimate of $3.92 billion.

(AGL) raised $1 billion in an IPO on Thursday, April 15th 2021. The company issued 46,600,000 shares at a price of $20.00-$23.00 per share. J.P. Morgan, Goldman Sachs, BofA Securities, Deutsche Bank Securities and Wells Fargo Securities acted as the underwriters for the IPO and William Blair, Truist Securities and Nomura were co-managers.

agilon health trades on the New York Stock Exchange (NYSE) under the ticker symbol "AGL."

agilon health's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Morgan Stanley (9.33%), Durable Capital Partners LP (2.15%), Brown Advisory Inc. (0.92%), T. Rowe Price Investment Management Inc. (0.66%), Geode Capital Management LLC (0.60%) and Norges Bank (0.33%). Insiders that own company stock include Benjamin Kornitzer, Benjamin Shaker, Cd&R Investment Associates Ix,, Clay Richards, Glenn Sobotka, Joan Danieley, John William Wulf, Michael L Smith, Steven Sell, Theodore Halkias and Veeral Desai.
View institutional ownership trends.

Shares of AGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of AGL stock can currently be purchased for approximately $28.69.

agilon health (NYSE:AGL) has a market capitalization of $11.85 billion and generates $2.71 billion in revenue each year. The company earns $-106,550,000.00 in net income (profit) each year or ($0.26) on an earnings per share basis.

The company employs 646 workers across the globe.

The official website for the company is agilonhealth.com. The company can be reached via phone at 562-256-3800 or via email at investor.relations@agilonhealth.com.